• TRELANSERIN chembl:CHEMBL3183740

    Alternate Names:

    TRELANSERIN
    SL65.0472

    Drug Info:

    FDA Approval not approved
    Drug Class small molecule
    Drug Indications for treatment of intermittent claudication
    (0 More Sources)

    Publications:

  • Interaction Score: 1.25

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Novel drug target Established target
    Trial Name trelanserin, SL 65.0472
    Mechanism of Interaction Serotonin 1b (5-HT1b) receptor antagonist

    PMIDs:
    None found


  • Interaction Score: 0.41

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist
    Direct Interaction yes
    Trial Name trelanserin, SL 65.0472

    PMIDs:
    None found


  • Interaction Score: 0.02

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    DTC